{"id":"W2139097830","doi":"10.1586/14737140.3.3.295","title":"Advances in targeted therapy for chronic myeloid leukemia","year":2003,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Imatinib mesylate; Imatinib; Leukemia; Targeted therapy; Immunology; Myeloid; Cancer research; Oncology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006345381,0.001103572,0.00633566,0.0002946884,0.00005906292,0.00001271968,0.000487389,0.0004154966,0.001234488],"category_scores_gemma":[0.0000999555,0.0007443342,0.001752504,0.0009097541,0.0002117857,0.0001656267,0.00002883396,0.0005016722,0.00003455324],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004604043,"about_ca_system_score_gemma":0.006300117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004563107,"about_ca_topic_score_gemma":0.000008908829,"domain_scores_codex":[0.9952779,0.0003123029,0.001977667,0.001043753,0.0005987161,0.0007896781],"domain_scores_gemma":[0.9968863,0.0003625352,0.00102778,0.001343965,0.0001981735,0.0001812272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001077133,0.0002111323,0.000005820921,0.09465235,0.0003912783,0.00001428961,0.00004787586,1.328762e-7,0.00001530912,0.00004869855,0.002489476,0.9020159],"study_design_scores_gemma":[0.004407742,0.0008572378,0.000003938168,0.1990384,0.0002057623,0.00004949606,0.000004797924,0.000002230114,0.0001196795,0.00001776064,0.7948044,0.0004885672],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004023131,0.988935,0.00004649498,0.0001444905,0.0005846922,0.009189886,0.00005914193,0.00005532895,0.0009809209],"genre_scores_gemma":[0.000001904851,0.9916111,0.001573234,0.001801995,0.0006493537,0.003412038,0.0003763535,0.0002314557,0.0003425482],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9015273,"threshold_uncertainty_score":0.9996785,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03901782163630336,"score_gpt":0.4007243942037427,"score_spread":0.3617065725674393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}